<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To detect the association between G870A polymorphism of cyclin D1 (CCND1) gene and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We performed a systematic literature and abstract search using PubMed, EMBase digital database </plain></SENT>
<SENT sid="2" pm="."><plain>Keywords included CCND1, cyclin D1, polymorphism, SNP, <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>. "And", "OR" and "NOT" were used as conjunction to narrow and widen the search </plain></SENT>
<SENT sid="3" pm="."><plain>Data were extracted by two investigators independently, and meta-analysis was carried out by using Review Manager 4.2.8 </plain></SENT>
<SENT sid="4" pm="."><plain>The following pairwised combinations of genotypes for the CCND1 G870A polymorphism were evaluated: AA vs. GG, AG vs. GG, AA+AG vs. GG </plain></SENT>
<SENT sid="5" pm="."><plain>Subsequently, sub-group analyses for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type, ethnicity, and the family history were performed </plain></SENT>
<SENT sid="6" pm="."><plain>Sensitivity analysis was conducted by excluding the articles deviated from Hardy-Weinberg equilibrium </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Using GG genotype as a reference, A carriers were associated with a significantly increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk (OR=1.15, 95%CI=1.06-1.25, P=0.001, P(<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>)=0.130), especially with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> (OR=1.24, 95%CI=1.02-1.51, P=0.030, P(<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>)=0.570) and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (OR=1.26, 95%CI=1.08-1.46, P=0.003, P(<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>)=0.730) </plain></SENT>
<SENT sid="8" pm="."><plain>The effect of A carriers on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> also existed in Caucasians (OR=1.19, 95%CI=1.06-1.32, P=0.002, P(<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>)=0.100) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: CCND1 G870A polymorphism is associated with the increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, especially for <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and in Caucasians </plain></SENT>
</text></document>